Company: VRCA
Filing Date: 2025-04-11
Form Type: PRE 14A
Source: 0001193125-25-079118
Chunk: 46

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-04-11
Form: PRE 14A
Chunk 46
---
 ASC Topic 718, Compensation-Stock Compensation. Consistent with the calculations contained in our financial statements, this calculation does not give effect to any estimate of forfeitures related to service-based vesting, but assumes that the executive will perform the requisite service for the award to vest in full. The assumptions we used in valuing options are described in Note 8 to our audited financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2024. |

| (3) | The amounts reflect the portion of each named executive officer’s target bonus earned based on the achievement of our corporate goals, which are discussed further below under “—Narrative to Summary Compensation Table—Annual Bonus.” |

| (4) | Dr. Rieger’s employment as our President and Chief Executive Officer began on November 6, 2024. Accordingly, Dr. Rieger was not a named executive officer for 2023 and, as a result, his compensation for that year has been omitted pursuant to applicable SEC rules and regulations. |

| (5) | Amount includes (a) 401(k) matching contributions of $13,800, (b) allowance for mobile phones of $600 and (c) life insurance premiums of $943. |

| (6) | Dr. Goldenberg was not a named executive officer for 2023 and, as a result, his compensation for that year has been omitted pursuant to applicable SEC rules and regulations. Dr. Goldenberg’s employment with us terminated in March 2025. |

| (7) | Amount includes (a) 401(k) matching contributions of $11,748, (b) allowance for mobile phones and internet of $1,500 and (c) life insurance premiums of $943. |

| (8) | Mr. White’s employment with us terminated in November 2024. |

35

| (9) | Amount includes (a) salary continuation payments of $624,624, (b) 401(k) matching contributions of $13,800, (c) reimbursement for continued health insurance premiums of $30,979, (d) allowance for mobile phones of $500 and (d) life insurance premiums of $943. |

| (10) | Mr. Bonaccorso’s employment with us terminated in August 2024. |

| (11) | Amount includes (a) salary continuation payments of $461,760, (b) 401(k) matching contributions of $